Mesa Laboratories, Inc. (NASDAQ:MLAB) Director John Bradley Schmieder sold 2,500 shares of the company’s stock in a transaction on Friday, February 8th. The shares were sold at an average price of $232.70, for a total transaction of $581,750.00. Following the completion of the sale, the director now owns 75,939 shares of the company’s stock, valued at approximately $17,671,005.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
MLAB opened at $234.33 on Monday. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.57 and a quick ratio of 1.29. Mesa Laboratories, Inc. has a 12 month low of $124.29 and a 12 month high of $239.08. The firm has a market capitalization of $906.51 million, a P/E ratio of 37.92 and a beta of 0.41.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 15th. Investors of record on Thursday, February 28th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date of this dividend is Wednesday, February 27th. Mesa Laboratories’s dividend payout ratio is currently 10.36%.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BB&T Corp boosted its stake in Mesa Laboratories by 5.6% in the 4th quarter. BB&T Corp now owns 1,990 shares of the medical instruments supplier’s stock worth $415,000 after purchasing an additional 105 shares during the period. PNC Financial Services Group Inc. boosted its stake in Mesa Laboratories by 19.8% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,424 shares of the medical instruments supplier’s stock worth $296,000 after purchasing an additional 235 shares during the period. Huntington National Bank acquired a new position in Mesa Laboratories in the 4th quarter worth $52,000. Sit Investment Associates Inc. boosted its stake in Mesa Laboratories by 18.5% in the 4th quarter. Sit Investment Associates Inc. now owns 1,600 shares of the medical instruments supplier’s stock worth $333,000 after purchasing an additional 250 shares during the period. Finally, Sapphire Star Partners LP boosted its stake in Mesa Laboratories by 5.0% in the 3rd quarter. Sapphire Star Partners LP now owns 5,619 shares of the medical instruments supplier’s stock worth $1,043,000 after purchasing an additional 268 shares during the period. Institutional investors and hedge funds own 70.40% of the company’s stock.
WARNING: This piece was first published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://dakotafinancialnews.com/2019/02/11/insider-selling-mesa-laboratories-inc-mlab-director-sells-581750-00-in-stock.html.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.
Recommended Story: How is Preferred Stock Different from Common Stock?
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.